News tagged with drug
Related topics: food and drug administration , patients , cancer , protein , cells
Look for new, improved sunscreen labels
(HealthDay)—New labeling laws for sunscreen will help American consumers choose the product that provides the best sun protection, experts say.
Health
May 10, 2013 |
not rated yet |
0
Research reveals possible reason for cholesterol-drug side effects
The U.S. Food and Drug Administration and physicians continue to document that some patients experience fuzzy thinking and memory loss while taking statins, a class of global top-selling cholesterol-lowering ...
Medical research
May 10, 2013 |
4.5 / 5 (11) |
13
|
Judge in NYC refuses to suspend his Plan B ruling
(AP)—A New York judge has refused to suspend his ruling giving women of all ages broad access to morning-after birth control.
Health
May 10, 2013 |
not rated yet |
0
FDA approves once-a-day inhaler from Glaxo
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.
Medications
May 10, 2013 |
not rated yet |
0
Discovery pinpoints cause of two types of leukemia, providing insights into new treatment approach
(Medical Xpress)—Patients with two forms of leukemia, who currently have no viable treatment options, may benefit from existing drugs developed for different types of cancer, according to a study conducted by researchers ...
Cancer
May 10, 2013 |
5 / 5 (1) |
0
|
Cancer drug prevents build-up of toxic brain protein
Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan ...
Genetics
May 10, 2013 |
5 / 5 (3) |
0
|
Methylphenidate 'normalizes' activation in key brain areas in kids with ADHD
The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. ...
Attention deficit disorders
May 09, 2013 |
5 / 5 (2) |
0
Popular diabetes drug does not improve survival rates after cancer
Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates ...
Diabetes
May 09, 2013 |
not rated yet |
0
Scientists show how nerve wiring self-destructs
Many medical issues affect nerves, from injuries in car accidents and side effects of chemotherapy to glaucoma and multiple sclerosis. The common theme in these scenarios is destruction of nerve axons, the ...
Neuroscience
May 09, 2013 |
5 / 5 (1) |
0
|
Ethics experts call for more thoughtful optimization of drug development process
(Medical Xpress)—McGill University post-doctoral fellow Spencer Phillips Hey and Prof. Jonathan Kimmelman, Biomedical Ethics, Social Studies of Medicine, Faculty of Medicine argue that some clinical trials of new drugs ...
Medications
May 09, 2013 |
not rated yet |
0
Anti-hypertension drug may improve schizophrenia symptoms
(Medical Xpress)—An anti-hypertension drug administered intravenously for a single four-hour treatment resulted in dramatic improvements of symptoms for people living with schizophrenia, according to newly published findings ...
Psychology & Psychiatry
May 09, 2013 |
5 / 5 (3) |
0
Wrigley takes new caffeinated gum off market
(AP)—A Food and Drug Administration investigation into the safety of caffeine-added foods has prompted Wrigley to take its new caffeinated gum off the market for the time being.
Health
May 09, 2013 |
not rated yet |
0
Scientists identify early predictors of disease progression which could speed Huntington's disease drug trials
Scientists have identified a set of tests that could help identify whether and how Huntington's disease (HD) is progressing in groups of people who are not yet showing symptoms. The latest findings from the TRACK-HD study, ...
Neuroscience
May 08, 2013 |
not rated yet |
0
Nearly 5 million asthmatics could benefit from antifungal therapy
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.
Inflammatory disorders
May 08, 2013 |
not rated yet |
0
Experimental drug beneficial in NIH trial to treat a rare sarcoma
(Medical Xpress)—Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib. The results from ...
Cancer
May 07, 2013 |
not rated yet |
0
